http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011098442-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19538b4ae3d63def32521ff377a29a07 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate | 2007-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f336c43239470e52e31a49da846b1b7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_107b03ff8747b889e0887b863af8be1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34bef6d961225e221be16014885b8fe9 |
| publicationDate | 2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2011098442-A1 |
| titleOfInvention | Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
| abstract | Peptides and peptide derivatives of the following general Formula (I): H 2 N-GHRPX 1 X 2 X 3 X 4 X 5 X 6 X 7 X 8 X 9 X 10 X 11 PX 12 PPPX 13 X 14 X 15 X 16 GYR—X 17 (I), wherein: X 1 -X 16 denote one of the 20 genetically encoded amino acids, X 17 denotes OR 1 , with R 1 =hydrogen or (C 1 -C 10 -alkyl), or NR 2 R 3 , R 2 and R 3 being identical or different and denoting hydrogen, (C 1 -C 10 )-alkyl, or a residue -PEG 5-60K , wherein the PEG-residue is linked to the N atom via a spacer, or a residue NH—Y-Z-PEG 5-60K , wherein Y denotes a chemical bond or a genetically coded amino acid from among the group of S, C, K or R, and Z denotes a spacer by way of which a polyethylene glycol (PEG)-residue may be linked, as well as the physiologically acceptable salts thereof, or wherein: X 15 or X 16 denotes an amino acid from the group of C or K, which is linked to a residue Z-PEG 5-60K via the heteroatom in the side chain, and wherein X 17 denotes OR 1 , with R 1 =hydrogen or (C 1 -C 10 -alkyl), or NR 2 R 3 , R 2 and R 3 being identical or different and denoting hydrogen or (C 1 -C 10 )-alkyl, as well as the physiologically acceptable salts thereof. |
| priorityDate | 2006-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 326.